Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,482,797
  • Shares Outstanding, K 126,303
  • Annual Sales, $ 484,330 K
  • Annual Income, $ -8,350 K
  • 60-Month Beta 1.18
  • Price/Sales 2.92
  • Price/Cash Flow 66.33
  • Price/Book 1.56
Trade NEO with:

Options Overview Details

View History
  • Implied Volatility 70.15% ( -2.83%)
  • Historical Volatility 62.44%
  • IV Percentile 12%
  • IV Rank 10.52%
  • IV High 178.12% on 05/11/22
  • IV Low 57.45% on 09/21/22
  • Put/Call Vol Ratio 0.76
  • Today's Volume 30
  • Volume Avg (30-Day) 217
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 7,616
  • Open Int (30-Day) 8,253

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.19
  • Number of Estimates 5
  • High Estimate -0.13
  • Low Estimate -0.24
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.44 +24.36%
on 01/09/23
13.48 -12.91%
on 02/02/23
+2.47 (+26.65%)
since 01/06/23
3-Month
7.01 +67.59%
on 11/07/22
13.48 -12.91%
on 02/02/23
+4.43 (+60.60%)
since 11/04/22
52-Week
6.00 +95.67%
on 10/24/22
23.78 -50.63%
on 02/10/22
-9.72 (-45.29%)
since 02/04/22

Most Recent Stories

More News
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company) (NASDAQ: NEO) and...

NEO : 11.74 (-6.45%)
NEOGENOMICS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NeoGenomics, Inc. ("NeoGenomics" or the...

NEO : 11.74 (-6.45%)
NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications...

NEO : 11.74 (-6.45%)
NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company”)...

NEO : 11.74 (-6.45%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired NeoGenomics,...

NEO : 11.74 (-6.45%)
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ:...

NEO : 11.74 (-6.45%)
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities...

NEO : 11.74 (-6.45%)
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO

/PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they...

NEO : 11.74 (-6.45%)
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NeoGenomics, Inc. (NASDAQ: NEO)

/PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a...

NEO : 11.74 (-6.45%)
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging...

NEO : 11.74 (-6.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 13.05
2nd Resistance Point 12.77
1st Resistance Point 12.26
Last Price 11.74
1st Support Level 11.47
2nd Support Level 11.19
3rd Support Level 10.68

See More

52-Week High 23.78
Fibonacci 61.8% 16.99
Fibonacci 50% 14.89
Fibonacci 38.2% 12.79
Last Price 11.74
52-Week Low 6.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar